Cost-effectiveness of general practitioner- versus surgeon-led colon cancer survivorship care: an economic evaluation alongside a randomised controlled trial

被引:0
|
作者
Vos, Julien A. M. [1 ,2 ]
El Alili, Mohamed [2 ,3 ]
Duineveld, Laura A. M. [1 ]
Wieldraaijer, Thijs [1 ]
Wind, Jan [1 ]
Sert, Edanur C. [1 ]
Donkervoort, Sandra [4 ]
Govaert, Marc J. P. M. [5 ]
van Geloven, Nanette A. W. [6 ]
van de Ven, Anthony W. H. [7 ]
Heuff, Gijsbert [8 ]
van Weert, Henk C. P. M. E. [1 ,2 ]
Bosmans, Judith M. [3 ]
van Asselt, Kristel [1 ,2 ]
机构
[1] Univ Amsterdam, Dept Gen Practice, Amsterdam UMC, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
[2] Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Fac Sci, Dept Hlth Sci, Boechorstr 7, NL-1081 BT Amsterdam, Netherlands
[4] OLVG Hosp, Dept Surg, Oosterpk 9, NL-1091 AC Amsterdam, Netherlands
[5] Dijklander Hosp, Dept Surg, Maelsonstr 3, NL-1624 NP Hoorn, Netherlands
[6] Tergooi Hosp, Dept Surg, Riebeeckweg 212, NL-1213 XZ Hilversum, Netherlands
[7] Flevoziekenhuis, Dept Surg, Hosp weg 1, NL-1315 RA Almere, Netherlands
[8] Spaarne Gasthuis, Dept Surg, Spaarnepoort 1, NL-2134 TM Hoofddorp, Netherlands
关键词
Colon cancer; Primary health care; Quality of healthcare; Cancer survivors; Cost-benefit analysis; QUALITY-OF-LIFE; HEALTH-CARE; FOLLOW-UP; QLQ-C30; MODELS;
D O I
10.1007/s11764-023-01383-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeThe aim of this study is to assess cost-effectiveness of general practitioner (GP) versus surgeon-led colon cancer survivorship care from a societal perspective.MethodsWe performed an economic evaluation alongside the I CARE study, which included 303 cancer patients (stages I-III) who were randomised to survivorship care by a GP or surgeon. Questionnaires were administered at baseline, 3-, 6-, 12-, 24- and 36-months. Costs included healthcare costs (measured by iMTA MCQ) and lost productivity costs (SF-HLQ). Disease-specific quality of life (QoL) was measured using EORTC QLQ-C30 summary score and general QoL using EQ-5D-3L quality-adjusted life years (QALYs). Missing data were imputed. Incremental cost-effectiveness ratios (ICERs) were calculated to relate costs to effects on QoL. Statistical uncertainty was estimated using bootstrapping.ResultsTotal societal costs of GP-led care were significantly lower compared to surgeon-led care (mean difference of - euro3895; 95% CI - euro6113; - euro1712). Lost productivity was the main contributor to the difference in societal costs (- euro3305; 95% CI - euro5028; - euro1739). The difference in QLQ-C30 summary score over time between groups was 1.33 (95% CI - 0.049; 3.15). The ICER for QLQ-C30 was - 2073, indicating that GP-led care is dominant over surgeon-led care. The difference in QALYs was - 0.021 (95% CI - 0.083; 0.040) resulting in an ICER of 129,164.ConclusionsGP-led care is likely to be cost-effective for disease-specific QoL, but not for general QoL.Implications for cancer survivorsWith a growing number of cancer survivors, GP-led survivorship care could help to alleviate some of the burden on more expensive secondary healthcare services.
引用
收藏
页码:1393 / 1402
页数:10
相关论文
共 50 条
  • [31] Cost-effectiveness of telephone coaching for physically inactive ambulatory care hospital patients: economic evaluation alongside the Healthy4U randomised controlled trial
    Barrett, Stephen
    Begg, Stephen
    O'Halloran, Paul
    Kingsley, Michael
    BMJ OPEN, 2019, 9 (12):
  • [32] Cost effectiveness of physiotherapy, manual therapy, and general practitioner care for neck pain. Economic evaluation alongside a randomized con trolled trial
    Korthals-de Bos, I.
    Hoving, J.
    van Tulder, M.
    Rutten-van Molken, P.
    Adler, H.
    de Vet, H.
    Koes, B.
    Vondeling, H.
    Bouter, L.
    MANUELLE MEDIZIN, 2005, 43 (05) : 311 - 318
  • [33] Cost-effectiveness of educational outreach to primary care nurses to increase tuberculosis case detection and improve respiratory care: economic evaluation alongside a randomised trial
    Fairall, Lara
    Bachmann, Max O.
    Zwarenstein, Merrick
    Bateman, Eric D.
    Niessen, Louis W.
    Lombard, Carl
    Majara, Bosielo
    English, Rene
    Bheekie, Angeni
    van Rensburg, Dingie
    Mayers, Pat
    Peters, Annatjie
    Chapman, Ronald
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2010, 15 (03) : 277 - 286
  • [34] Cost-Effectiveness of One Year Dementia Follow-Up Care by Memory Clinics or General Practitioners: Economic Evaluation of a Randomised Controlled Trial
    Meeuwsen, Els
    Melis, Rene
    van der Aa, Geert
    Goluke-Willemse, Gertie
    de Leest, Benoit
    van Raak, Frank
    Scholzel-Dorenbos, Carla
    Verheijen, Desiree
    Verhey, Frans
    Visser, Marieke
    Wolfs, Claire
    Adang, Eddy
    Rikkert, Marcel Olde
    PLOS ONE, 2013, 8 (11):
  • [35] Person-Centred Care in Patients with Acute Coronary Syndrome: Cost-Effectiveness Analysis Alongside a Randomised Controlled Trial
    Pirhonen, Laura
    Bolin, Kristian
    Olofsson, Elisabeth Hansson
    Fors, Andreas
    Ekman, Inger
    Swedberg, Karl
    Gyllensten, Hanna
    PHARMACOECONOMICS-OPEN, 2019, 3 (04) : 495 - 504
  • [36] Person-Centred Care in Patients with Acute Coronary Syndrome: Cost-Effectiveness Analysis Alongside a Randomised Controlled Trial
    Laura Pirhonen
    Kristian Bolin
    Elisabeth Hansson Olofsson
    Andreas Fors
    Inger Ekman
    Karl Swedberg
    Hanna Gyllensten
    PharmacoEconomics - Open, 2019, 3 : 495 - 504
  • [37] Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial
    Rikke Søgaard
    Barbara Malene B. Fischer
    Jann Mortensen
    Liselotte Højgaard
    Ulrik Lassen
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 802 - 809
  • [38] Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial
    Sogaard, Rikke
    Fischer, Barbara Malene B.
    Mortensen, Jann
    Hojgaard, Liselotte
    Lassen, Ulrik
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (05) : 802 - 809
  • [39] Cost-Effectiveness of Dementia Care Mapping in Care-Home Settings: Evaluation of a Randomised Controlled Trial
    David M. Meads
    Adam Martin
    Alys Griffiths
    Rachael Kelley
    Byron Creese
    Louise Robinson
    Joanne McDermid
    Rebecca Walwyn
    Clive Ballard
    Claire A. Surr
    Applied Health Economics and Health Policy, 2020, 18 : 237 - 247
  • [40] Cost-Effectiveness of Dementia Care Mapping in Care-Home Settings: Evaluation of a Randomised Controlled Trial
    Meads, David M.
    Martin, Adam
    Griffiths, Alys
    Kelley, Rachael
    Creese, Byron
    Robinson, Louise
    McDermid, Joanne
    Walwyn, Rebecca
    Ballard, Clive
    Surr, Claire A.
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2020, 18 (02) : 237 - 247